These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 4937675)

  • 1. Current problems in prophylactic treatment of Rh-erythroblastosis.
    J Reprod Med; 1971 May; 6(5):232-55. PubMed ID: 4937675
    [No Abstract]   [Full Text] [Related]  

  • 2. Effectiveness of Rh prophylaxis.
    Woodrow JC
    Haematologia (Budap); 1974; 8(1-4):281-90. PubMed ID: 4218822
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prevention of Rhesus sensitization using anti-D, ten years after initiation of the first studies].
    Schneider J
    Z Geburtshilfe Perinatol; 1972 Feb; 176(1):2-16. PubMed ID: 4553933
    [No Abstract]   [Full Text] [Related]  

  • 4. Some residual problems concerning Rh prophylaxis.
    Finn R
    Ann Ostet Ginecol Med Perinat; 1970 Jul; 92(7):436-9. PubMed ID: 5003521
    [No Abstract]   [Full Text] [Related]  

  • 5. [Prophylaxis against Rh-immunization].
    Josephson B
    Lakartidningen; 1970 Dec; 67(51):6037-40. PubMed ID: 4992842
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevention of Rh hemolytic disease.
    Pollack W; Gorman JG; Freda VJ
    Prog Hematol; 1969; 6():121-47. PubMed ID: 4976484
    [No Abstract]   [Full Text] [Related]  

  • 7. The future of Rh immune globulin.
    Gorman JG
    Ann Ostet Ginecol Med Perinat; 1970 Jul; 92(7):422-6. PubMed ID: 5003518
    [No Abstract]   [Full Text] [Related]  

  • 8. The management of large Rh o (D) incompatible feto-maternal bleedings with anti-Rh o (D) immunoglobulins.
    Vermylen C
    Ann Ostet Ginecol Med Perinat; 1970 Jul; 92(7):451. PubMed ID: 5526985
    [No Abstract]   [Full Text] [Related]  

  • 9. [Selective Rh prevention in pregnancy].
    Helderweirt G
    Verh K Acad Geneeskd Belg; 1983; 45(3):261-74. PubMed ID: 6421025
    [No Abstract]   [Full Text] [Related]  

  • 10. Some epidemiological aspects of the prevention of Rh isoimmunization.
    Walker W
    Ann Ostet Ginecol Med Perinat; 1970 Jul; 92(7):431-5. PubMed ID: 5003520
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prevention of Rhesus-sensitization by intravenous administration of immunoglobulin G anti-D. II. General prevention using low doses of IgG anti-D, adapted to the extent of fetomaternal transfusion].
    Börner P; Deicher H; Ghani G; Geldmacher H; Kayser D; Kahnt P; Klang D; Klaus H; Marks V; Nehawandian OA
    Geburtshilfe Frauenheilkd; 1971 Oct; 31(10):911-23. PubMed ID: 5002413
    [No Abstract]   [Full Text] [Related]  

  • 12. [Practical problems of preventing Rh sensitization using immunological methods].
    Althoff W; Schellong G; Stahl M
    Rev Clin Esp; 1969 Sep; 114(6):515-24. PubMed ID: 4988856
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prevention of fetomaternal immunizations].
    Mahon R; Moulinier J; Dubecq JP; Lepage F; Ravina JH; Landeau MC
    J Gynecol Obstet Biol Reprod (Paris); 1972; 1():Suppl 1:3-50. PubMed ID: 4634195
    [No Abstract]   [Full Text] [Related]  

  • 14. Prophylaxis of maternal RH-sensitization by means of anti-D immunoglobulin.
    Petrov-Maslakov MA; Vasilyeva ZF; Matveyeva OF; Balasanyan IG; Sorina LI; Prigarnova TK
    Arch Immunol Ther Exp (Warsz); 1971; 19(3):343-8. PubMed ID: 4999474
    [No Abstract]   [Full Text] [Related]  

  • 15. Successful prophylaxis of Rh immunization using small doses of intravenous anti-D IgG.
    Borner P; Deicher H
    Ann Ostet Ginecol Med Perinat; 1970 Jul; 92(7):453-4. PubMed ID: 5003526
    [No Abstract]   [Full Text] [Related]  

  • 16. [On the prevention of Rh immunization in Sweden].
    Bartsch FK; Bergman PO; Bååthe P; Dahlen-Nilsson I; Hansson LA; Ryttinger LA
    Bibl Haematol; 1969; 32():135-40. PubMed ID: 4980799
    [No Abstract]   [Full Text] [Related]  

  • 17. [Practical experiences with the anti-D-IgG prevention of Rh-immunization].
    Bergmann H; Leinzinger E; Pazdernik I; Haider M
    Wien Med Wochenschr; 1969 Jan; 119(1):9-12. PubMed ID: 4975236
    [No Abstract]   [Full Text] [Related]  

  • 18. [The causes of failures in post partum Anti-D-prophylaxis. 2. Sensitizations prior to the administration of Anti-D-immunoglobulin (author's transl)].
    Bartsch FK; Schneider J
    Geburtshilfe Frauenheilkd; 1973 Oct; 33(10):806-15. PubMed ID: 4203352
    [No Abstract]   [Full Text] [Related]  

  • 19. Rh prophylactic treatment during pregnancy. An attempt to select for treatment those at possible risk.
    Pollock J; Lewis M; Kaita H; Chown B; Bowman JM
    Vox Sang; 1974; 26(1):26-33. PubMed ID: 4214337
    [No Abstract]   [Full Text] [Related]  

  • 20. [Improved prognosis of fetal erythroblastosis through the variation of prophylactic and therapeutic measures].
    Verron G; Radzuweit H; Schubert W; Brockmann J
    Dtsch Gesundheitsw; 1970 Oct; 25(40):1906-10. PubMed ID: 4991821
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.